News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
PERRY MATTHEW D
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/19/2023 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns:
| Granted 10,967 options to buy
@ $21.39, valued at
$234.6k
|
|
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2020 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns:
| Bought 200,000 shares
@ $25, valued at
$5M
|
|
05/27/2020 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns:
| Granted 6,152 options to buy
@ $21.27, valued at
$130.9k
|
|
05/20/2019 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns:
| Granted 120,000 options to buy
@ $0.8411, valued at
$100.9k
|
|
05/20/2019 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns:
| Granted 8,167 options to buy
@ $15.59, valued at
$127.3k
|
|
05/21/2018 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp
Txns:
| Granted 5,052 options to buy
@ $25.16, valued at
$127.1k
|
|
05/21/2018 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns:
| Granted 60,000 options to buy
@ $4.61, valued at
$276.6k
|
|
05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/03/2016 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns:
| Granted 347,360 options to buy
@ $0 |
|
01/13/2016 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns:
| Granted 84,034 options to buy
@ $0 |
|
|
|